Related Experiment Videos
Management of valvular stenosis
1Division of Cardiology, Hammersmith Hospital, London, UK.
Insights
Interventional cardiology has transformed valvular stenosis management. Balloon valvuloplasty is now a key treatment for mitral stenosis, especially in younger patients, while aortic valve replacement remains crucial for aortic stenosis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Background:
- Management of valvular stenosis has evolved significantly due to advancements in interventional cardiology over the last 15 years.
- Early attempts with balloon valvuloplasty for aortic stenosis in the elderly were largely abandoned, with aortic valve replacement becoming a safer and more effective option.
- Mitral stenosis, unlike aortic stenosis, is a disabling condition where intervention timing is complex due to treatment choices and patient factors.
Purpose of the Study:
- To review the evolution of valvular stenosis management, focusing on the impact of interventional cardiology.
- To compare the roles of balloon valvuloplasty and surgical interventions for aortic and mitral stenosis.
- To highlight the current indications and outcomes for mitral balloon valvuloplasty, particularly with the Inoue balloon.
Main Methods:
- Review of historical treatment paradigms for valvular stenosis.
- Discussion of the comparative efficacy and safety of balloon valvuloplasty versus surgical valve replacement.
- Emphasis on the role of echocardiography in assessing valve stenosis and left ventricular function.
- Acknowledgement of the continued necessity of coronary angiography in specific patient cohorts.
Main Results:
- Balloon valvuloplasty for aortic stenosis in the elderly infirm initially showed promise but was superseded by aortic valve replacement.
- Mitral balloon valvuloplasty, particularly using the Inoue balloon, has become a preferred treatment for young patients with specific valve characteristics.
- Echocardiography has largely replaced cardiac catheterization for evaluating valve stenosis and ventricular function, except when coronary angiography is indicated.
Conclusions:
- Interventional cardiology has revolutionized valvular stenosis treatment, offering new therapeutic avenues.
- Mitral balloon valvuloplasty is a valuable option, especially for younger patients, and provides palliation for older patients.
- The choice of intervention for valvular stenosis requires careful consideration of disease type, patient age, valve morphology, and comorbidities.
Abstract:
The management of valvular stenosis has changed dramatically over the past 15 years, largely due to interventional cardiology. At the beginning of the 1980s, balloon valvuloplasty was thought by many to represent a definitive new treatment for calcific aortic stenosis in the elderly infirm. Before the end of the decade, this treatment had gone out of favor, but by that time we had learned that many of those same patients could undergo aortic valve replacement relatively safely and with excellent results. Unlike aortic stenosis, mitral stenosis is a disabling rather than a lethal disease, so the timing of intervention is much more difficult, particularly as there are treatment choices. Mortality, morbidity, and the possible bonus from proceeding earlier rather than later all need to be taken into consideration. Much to many people's surprise, mitral balloon valvuloplasty has grown and prospered, especially since the introduction of the Inoue balloon. It is the treatment of choice for young patients with mobile, noncalcified, stenosed valves, although still offering worthwhile palliation for older patients with higher echocardiographically determined valve scores. Echocardiography has gradually usurped cardiac catheterization for the assessment of valve stenosis and left ventricular function, but in patients with concomitant coronary disease that will be treated at the same time, the need for coronary angiography remains almost unchallenged.